APYX — Apyx Medical Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 719135 ·
Last close
$4.10
Market Cap
$172.65M
52W High
$5.08
52W Low
$2.76
ADV30
86,696
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 12,490,000 | 7,925,000 | -911,000 | -2,108,000 | 63,025,000 | 31,137,000 | 49,937,000 |
| Dec 2025 | 19,164,000 | 11,999,000 | 11,000 | -1,299,000 | 66,840,000 | 31,740,000 | 52,009,000 |
| Sep 2025 | 12,877,000 | 8,297,000 | -832,000 | -1,984,000 | 57,365,000 | 25,135,000 | 51,285,000 |
| Jun 2025 | 11,373,000 | 7,083,000 | -2,574,000 | -3,778,000 | 58,188,000 | 29,301,000 | 50,732,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,001,000
Investing CF
$-1,114,000
Financing CF
$9,580,000
CapEx
$-1,114,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.27
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-89,122,000
Inventory
$8,602,000
Receivables
$16,776,000
ST Investments
—
EBIT TTM
$-5,246,000
Pretax Income TTM
$-10,835,000
Interest Exp TTM
$5,589,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$55,904,000
EBITDA
$-3,587,000
Free Cash Flow
$-7,666,000
Enterprise Value
$181,100,672
Total Cash
$31,137,000
Total Debt
$39,461,000
Shares Out
42,110,354
Trailing EPS
$-0.22
Book Value
$0.31
ROE
-76.5%
ROA
-4.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 52,844,000 | -6,446,000 | -11,211,000 | 66,840,000 | 52,009,000 | — | -8,001,000 |
| Dec 2024 | 48,102,000 | -18,845,000 | -23,463,000 | 64,842,000 | 50,507,000 | — | -18,047,000 |
| Dec 2023 | 52,349,000 | -19,951,000 | -18,713,000 | 79,240,000 | 52,318,000 | — | -5,249,000 |
| Dec 2022 | 44,510,000 | -23,562,000 | -23,184,000 | 51,775,000 | 13,982,000 | — | -20,280,000 |
TTM Snapshot
Revenues TTM
$41,468,000
NetIncome TTM
$-14,708,000
OpCashFlow TTM
$0
Assets (Latest)
$79,240,000
Forward EPS
$-0.25
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INGN | Inogen Inc | $174.63M | $6.45 | — |
| LUCD | Lucid Diagnostics Inc. | $166.28M | $0.87 | — |
| INFU | InfuSystem Holdings, Inc | $184.46M | $9.14 | — |
| PDEX | PRO DEX INC | $187.00M | $58.57 | — |
| EBRCZ | EBR Systems, Inc. | $158.19M | $0.21 | — |
News headlines (Yahoo Finance, 1h cache)
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-28 12:00 · Yahoo
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
2026-07-23 12:00 · Yahoo
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity
2026-06-19 18:21 · Yahoo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals
2026-06-01 14:05 · Yahoo
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway
2026-05-27 12:00 · Yahoo
What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play
2026-05-21 23:05 · Yahoo
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth
2026-05-21 22:45 · Yahoo
What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year
2026-05-21 22:28 · Yahoo
This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares
2026-05-21 22:09 · Yahoo
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
2026-05-21 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.